NYSE ARCA | ETF
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies.
From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 8.12% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 6.02% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.35% |
| NVZMY | Novozymes AS | Basic Materials | Specialty Chemicals | 4.78% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 4.65% |
| NVDA | NVIDIA Corporation | Technology | Semiconductors | 4.60% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.51% |
| BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 4.42% |
| CDNS | Cadence Design Systems Inc | Technology | Software - Application | 4.02% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 3.52% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.40% |
| DD | Dupont De Nemours Inc | Basic Materials | Specialty Chemicals | 3.38% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.37% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.26% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.13% |
| GOOGL | Alphabet Inc Class A | Communication Services | Internet Content & Information | 2.96% |
| NGVT | Ingevity Corp | Basic Materials | Specialty Chemicals | 2.85% |
| DAR | Darling Ingredients Inc | Consumer Defensive | Packaged Foods | 2.61% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.47% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.15% |